Although vorinostat has shown promise in treating certain cancers, there are limitations. Its effectiveness may vary among different types of cancers and individual patients. Resistance to vorinostat can develop, making it less effective over time. Additionally, the side effect profile can limit its use, especially in patients with pre-existing conditions.
